Genexine Inc.

City:

Seoul

Country:

South Korea

Published Applications:

Last publication date:

2025-06-12

Patent Grants:

Last grant date:

2013-11-19

Top Inventors for applications by Genexine Inc.

These are the the leading inventors for applications assigned to Genexine Inc.:

Young Chul Sung 2 Pohang-si, South Korea
Young Chul SUNG 2 Seoul, South Korea
Young Chul Sung 1 Gyeongsangbuk-do, South Korea
Chang Gon KIM 1 Seoul, South Korea

Chanwoong PARK 1 Siheung-si, Gyeonggi-do, South Korea
Se-Hwan Yang 1 Pohang-si, South Korea
Jin-won Youn 1 Incheon-si, South Korea
Su-hyung PARK 1 Seoul, South Korea

Hye Ryun KIM 1 Seoul, South Korea
Sehwan YANG 1 Gyeongbuk, South Korea
Jung-Won WOO 1 Seoul, South Korea
Mun Gu KIM 1 Pohang-si, South Korea

Sei Kwang Hahn 1 Pohang-si, South Korea
Se-Hwan Yang 1 Gyeongsangbuk-do, South Korea
Chang Geun Lee 1 Daegu-si, South Korea
Hwan Hee KIM 1 Seoul, South Korea

Daham Jeong 1 Seoul, South Korea
Ki-Yong KIM 1 Yongin-si, Gyeonggi-do, South Korea
Min Hee HONG 1 Seoul, South Korea

Recent patent applications by Genexine Inc.

Genexine Inc. based in Seoul, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-06-12

US20250188182A1

Chemistry; metallurgy

TRIPLE COMBINATION DRUG DOSING THERAPY FOR HEAD AND NECK CANCER TREATMENT

#2 | 2025-01-23

US20250026804A1

Chemistry; metallurgy

HIGH-CONCENTRATION ADMINISTRATION FORMULATION OF HGH FUSION PROTEIN

#3 | 2025-01-23

US20250025418A1

Human necessities

HYALURONIC ACID-LIPID DERIVATIVE, LIPID NANOPARTICLE COMPRISING SAME, AND USE THEREOF

#4 | 2012-11-01 ✅ Patent 8,586,048 granted on 2013-11-19

US20120276043A1

Chemistry; metallurgy

G-CSF immunoglobulin fusion proteins

#5 | 2005-12-29 ✅ Patent 7,989,425 granted on 2011-08-02

US20050287117A1

Human necessities

Vaccine enhancing the protective immunity to hepatitis c virus using plasmid DNA and recombinant adenovirus

Also check out GENEXINE, INC.'s (Seoul, South Korea) applicant profile with 3 patent applications submitted.

AssigneeID:

305887 ⎘